News

Amprius Technologies Addresses Recent NYSE Compliance Notice

Amprius Technologies Addresses Recent NYSE Compliance Notice

Challenges with NYSE Compliance for Amprius Technologies

Recently, Amprius Technologies, Inc. (NYSE: AMPX) received a notification from the New York Stock Exchange (NYSE) concerning its compliance with listing standards. This notice indicates that the company's common stock has fallen below the required average closing price of $1.00 over a 30-day trading span. It’s important to highlight that this notice points to a deficiency rather than an immediate delisting, meaning Amprius' shares will continue to trade on the NYSE while the company evaluates its options.

Grasping the NYSE Listing Rule

According to the NYSE Listing Rule, Amprius is required to take measures to rectify this deficiency. The company has a window of six months to restore compliance. This can be achieved if the stock price reaches at least $1.00 on the final trading day of any month, maintaining an average closing price of at least that amount for the following 30 trading days. This recent notice acts as a prompt for Amprius to rethink and adapt its market strategies efficiently.

Amprius Technologies' Focus on Compliance

Amprius Technologies is dedicated to maintaining its NYSE listing and is actively exploring various strategies to regain compliance. The company assures stakeholders that the NYSE's notice doesn’t present an immediate risk to its operations or its reporting obligations with the U.S. Securities and Exchange Commission (SEC). As Amprius moves ahead, its main priority remains to protect the interests of its shareholders and stakeholders.

Effect on Business Operations

This compliance notice has sparked discussions about its potential impact on Amprius' core business activities. Nevertheless, the company reassures its partners and customers that its business operations are strong and unaffected by this situation. Amprius remains committed to delivering high-quality lithium-ion batteries, evidenced by impressive performance metrics in energy density and efficiency.

About Amprius Technologies, Inc.

Amprius Technologies, Inc. is widely recognized for its expertise in producing high-energy and high-power lithium-ion batteries. The company boasts the highest energy density cells available in the industry, featuring SiMaxx™ batteries that achieve remarkable energy metrics of up to 450 Wh/kg and 1,150 Wh/L. In its efforts to broaden its product range, Amprius has also introduced the SiCore™ platform, further enhancing its ability to meet the diverse needs of its customers. With manufacturing and R&D facilities situated in Fremont, Amprius is positioned to maintain competitive advantages and drive growth within the battery sector.

Boosting Manufacturing Capabilities

To address growing customer demands, Amprius has secured agreements for over 500 MW/h of contract manufacturing capacity. Additionally, they’ve committed to building a gigawatt-hour-scale facility in Brighton, Colorado, which will greatly enhance their production capabilities. This strategic decision underscores the company's commitment to innovation and expansion in the market.

Looking Ahead

As Amprius faces this challenge from the NYSE, it will concentrate on regaining compliance while simultaneously developing cutting-edge battery technologies. Ongoing investments in research and development, along with strategic partnerships, align with the company's vision to lead the market in high-performance battery solutions.

Frequently Asked Questions

What is the current status of Amprius Technologies on the NYSE?

Amprius Technologies remains listed on the NYSE despite receiving a compliance notice. The company has a six-month period to rectify the deficiency.

How is Amprius planning to regain compliance with the NYSE?

The company aims to comply by ensuring its stock price exceeds $1.00 on the last trading day of any month within the specified six-month timeframe.

Will the compliance notice affect Amprius' business operations?

No, the compliance notice is not expected to influence Amprius Technologies' ongoing business operations or its reporting with the SEC.

What products does Amprius Technologies manufacture?

Amprius produces high-energy and high-power lithium-ion batteries, including its SiMaxx™ series and the newly launched SiCore™ batteries.

Where is the headquarters of Amprius Technologies located?

The corporate headquarters of Amprius Technologies is situated in Fremont, California, where they also have a manufacturing facility and R&D lab.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ares Commercial Real Estate Gears Up for Q3 Earnings

Updated Category News Views 21

Earnings Season Descends on Ares Commercial Real Estate The hush before the storm is here, comrades. Ares Commercial Real Estate Corporation (NYSE: ACRE) has set the ticker tape rolling as they prepare to unveil the fiscal secrets of their third quarter on November 6, 2026. If you’ve got skin in the game or just an ear for market music, mark your calendars because the...

Continue Reading
HumanView Relaunch: LEAP Group Decodes Customer Signals

Updated Category News Views 52

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 44

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 180

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading

Top 5 Most Recently Viewed Articles

Columbus McKinnon Completes Significant Notes Offering for Growth

Updated Category News Views 97

Columbus McKinnon Completes Important Notes Offering Columbus McKinnon Corporation (NASDAQ: CMCO), a prominent designer and manufacturer in the intelligent motion solutions sector, has successfully completed a notable offering of senior secured notes. This offering totaled $900 million with a set interest rate of 7.125%, maturing in 2033, aimed at supporting the company's...

Continue Reading
Navigating TransMedics Gr's Upcoming Earnings Like a Pro

Updated Category News Views 195

Rollin' into Earnings: What to Expect from TMDX Every now and then, a company catches wind in its sails, and TransMedics Gr (NASDAQ:TMDX)—well, it’s been riding a decent wave lately. With earnings about to drop on February 24, 2026, folks are buzzing, holding their breath, and looking for that golden info nugget to drop. Analysts are pinning their hopes on an earnings...

Continue Reading
Rigel Pharmaceuticals Set to Showcase Innovations at J.P. Morgan

Updated Category News Views 108

Rigel Pharmaceuticals Gears Up for J.P. Morgan Healthcare Conference Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a prominent name in biotechnology focused on hematologic disorders and cancer treatments, is poised to make a significant impact at the upcoming J.P. Morgan Healthcare Conference. The event is set to bring together industry leaders and innovators, making it an...

Continue Reading
Big Lots Introduces Festive Shopping Event Amid Holiday Cheers

Updated Category News Views 293

Exciting Updates from Big Lots This Holiday Season Big Lots is gearing up for the holiday season with some thrilling news for all shoppers. The launch of their new Holiday Shop is set to delight customers, combined with an unforgettable one-day shopping event called ‘Falloweenmas’ which offers great savings and unique decorations for this festive time of year....

Continue Reading
Amcor Welcomes Stephen Scherger as New CFO Amid Changes

Updated Category News Views 273

Amcor Announces New Leadership with Stephen R. Scherger Amcor, a global frontrunner in packaging solutions, has appointed Stephen R. Scherger as its new Executive Vice President and Chief Financial Officer, effective November 10, 2025. This decision comes as the current CFO, Michael Casamento, steps down after dedicating a decade to the company. He will continue in an...

Continue Reading